Overview

Lovastatin: Immunomodulatory Value Evaluation

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the long-term administration of statins may benefit the clinical and immunological evolution in HIV-1-infected individuals before the use of antiretroviral therapy is required.
Phase:
Phase 2
Details
Lead Sponsor:
Universidad de Antioquia
Collaborators:
Humax Pharmaceutical
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)
Laboratorio Clínico Congregación Mariana
Laboratorios Laproff S.A.
Treatments:
Dihydromevinolin
L 647318
Lovastatin